Khaled Musallam: Navigating the Complex Paradoxes of Non-Transfusion-Dependent Thalassemia
Khaled Musallam, Group Chief Research Officer at Burjeel Holdings, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Blood Reviews, adding:
”One of the papers I enjoyed working on the most this year, presenting non-transfusion-dependent thalassemia (NTDT) through the lens of its many clinical paradoxes. Out today in Blood Reviews.
We specifically developed the figures to serve as simple, practical, and easy-to-reference visual guides for clinicians navigating the complexities of NTDT.”
Ttitle: Non-transfusion-dependent β-thalassemia: A disease of clinical paradoxes
Authors: Khaled M. Musallam, Sujit Sheth, Gian Luca Forni, Farrukh T. Shah, Maria Domenica Cappellini, Ali T. Taher
Find more posts featuring Khaled Musallam on Hemostasis Today.
-
Aug 29, 2026, 17:05What If Factor XI inhibition Could Reshape the Future of Anticoagulation – ISTH
-
Aug 29, 2026, 16:44Nipocalimab for Warm Autoimmune Hemolytic Anemia: What the FDA Approval Means
-
Aug 29, 2026, 16:17The Future of Bleeding Disorder Research is Getting Bigger – Global Hemophilia Report
-
Aug 29, 2026, 16:03Marco De Giovanni: The Platelet – Serotonin Link Behind Severe COVID-19
-
Aug 29, 2026, 16:01FDA Approves Imaavy for wAIHA – Thalassaemia International Federation
-
Aug 29, 2026, 16:00Dianne E. van der Wal: Advancing Platelet Research at ISTH 2026 in Paris
-
Aug 29, 2026, 15:55Cory Dugan: Iron Deficiency and Anemia Across the Female Life
-
Aug 29, 2026, 15:53Melina Rodriguez: FDA Approves Imaavy as First Treatment for Warm AIHA
-
Aug 29, 2026, 15:50Karen T․: Seeking a Patient Liaison to Support the Bleeding Disorders Community